Quadrant Capital Group’s Relay Therapeutics RLAY Stock Holding History

Quadrant Capital Group’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$117K	Hold	11,791	–	–	﹤0.01%	1437
2025 Q4	$99.8K	Hold	11,791	–	–	﹤0.01%	1488
2025 Q3	$61.5K	Hold	11,791	–	–	﹤0.01%	1599
2025 Q2	$40.8K	Buy	11,791 +8,374	+245%	+$24.9K	﹤0.01%	1328
2025 Q1	$8.95K	Buy	3,417 +2,972	+668%	+$11.6K	﹤0.01%	2240
2024 Q4	$1.83K	Buy	445 +394	+773%	+$2.14K	﹤0.01%	2505
2024 Q3	$362	Sell	51 -1,045	-95%	-$7.81K	﹤0.01%	2679
2024 Q2	$7.15K	Buy	+1,096	New	+$7.49K	﹤0.01%	2207
2023 Q1	–	Sell	-72	Closed	-$1.08K	–	2779
2022 Q4	$1.08K	Buy	+72	New	+$1.38K	﹤0.01%	2535

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return